Rituximab in ANCA-Associated Vasculitis: Fad or Fact?

被引：9

作者：

Fervenza, Fernando C. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Nephrol & Hypertens, Rochester, MN 55901 USA

来源：

NEPHRON CLINICAL PRACTICE | 2011年 / 118卷 / 02期

关键词：

Rituximab; High-dose glucocorticosteroids; Cyclophosphamide; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHURG-STRAUSS-SYNDROME; REFRACTORY WEGENERS-GRANULOMATOSIS; B-LYMPHOCYTE DEPLETION; MICROSCOPIC POLYANGIITIS; MAINTENANCE THERAPY; CYCLOPHOSPHAMIDE; RELAPSE; CELLS;

D O I：

10.1159/000321437

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A number of case reports and case series of patients with Wegener's granulomatosis, microscopic polyangiitis and Churg-Strauss syndrome have supported the use of rituximab (RTX) for the treatment of refractory ANCA-associated vasculitis (AAV). Whether B cell depletion with RTX could replace cyclophosphamide as a first-line therapy for patients with severe AAV remains to be proven. Two studies, recently published in the New England Journal of Medicine, have examined the efficacy of RTX in inducing remission in patients with severe AAV. Copyright (C) 2010 S. Karger AG, Basel

引用

页码：C182 / C188

页数：7

共 50 条

[31] Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course [J].

Tariq, Anam ;

Akenroye, Ayobami ;

Azar, Antoine ;

Seo, Philip ;

Geetha, Duvuru .

EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (02) :93-99

[32] Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis [J].

Smith, Rona M. ;

Jones, Rachel Bronwen ;

Specks, Ulrich ;

Bond, Simon ;

Nodale, Marianna ;

Aljayyousi, Reem ;

Andrews, Jacqueline ;

Bruchfeld, Annette ;

Camilleri, Brian ;

Carette, Simon ;

Cheung, Chee Kay ;

Derebail, Vimal ;

Doulton, Tim ;

Forbess, Lindsy ;

Fujimoto, Shouichi ;

Furuta, Shunsuke ;

Gewurz-Singer, Ora ;

Harper, Lorraine ;

Ito-Ihara, Toshiko ;

Khalidi, Nader ;

Klocke, Rainer ;

Koening, Curry ;

Komagata, Yoshinori ;

Langford, Carol ;

Lanyon, Peter ;

Luqmani, Raashid Ahmed ;

Makino, Hirofumi ;

McAlear, Carole ;

Monach, Paul ;

Moreland, Larry W. ;

Mynard, Kim ;

Nachman, Patrick ;

Pagnoux, Christian ;

Pearce, Fiona ;

Peh, Chen Au ;

Pusey, Charles ;

Ranganathan, Dwarakanathan ;

Rhee, Rennie L. ;

Spiera, Robert ;

Sreih, Antoine G. ;

Tesar, Vladimir ;

Walters, Giles ;

Weisman, Michael H. ;

Wroe, Caroline ;

Merkel, Peter ;

Jayne, David .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (09) :1243-1249

[33] The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis [J].

Okada, Masahiro ;

Suemori, Koichiro ;

Takagi, Daiki ;

Teraoka, Masato ;

Yamada, Hiroyuki ;

Ishizaki, Jun ;

Matsumoto, Takuya ;

Hasegawa, Hitoshi ;

Hato, Naohito .

AURIS NASUS LARYNX, 2019, 46 (01) :38-42

[34] Low-dose rituximab as induction therapy for ANCA-associated vasculitis [J].

Takakuwa, Yukiko ;

Hanaoka, Hironari ;

Kiyokawa, Tomofumi ;

Iida, Harunobu ;

Fujimoto, Hisae ;

Yamasaki, Yoshioki ;

Yamada, Hidehiro ;

Kawahata, Kimito .

CLINICAL RHEUMATOLOGY, 2019, 38 (04) :1217-1223

[35] Successful Treatment of ANCA-Associated Vasculitis in the Setting of Common Variable Immunodeficiency Using Rituximab [J].

Hill, Frank ;

Yonkof, Jennifer ;

Arudra, Sri K. Chaitanya ;

Thomas, Jean ;

Altorok, Nezam .

AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (05) :E1239-E1245

[36] Rituximab for ANCA-associated vasculitides [J].

Guillevin, L. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) :S118-S121

[37] ANCA-Associated Vasculitis: An Update [J].

Almaani, Salem ;

Fussner, Lynn A. ;

Brodsky, Sergey ;

Meara, Alexa S. ;

Jayne, David .

JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)

[38] Rituximab-associated hypogammaglobulinaemia in ANCA-associated vasculitis and connective tissue diseases: a longitudinal observational study [J].

Padoan, R. ;

Felicetti, M. ;

Gatto, M. ;

Polito, P. ;

Doria, A. ;

Schiavon, F. .

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) :S188-S194

[39] Empfehlungen zum Einsatz von Rituximab bei ANCA-assoziierten VaskulitidenRecommendations on the use of rituximab for ANCA-associated vasculitis [J].

A.M. Gause ;

A. Rubbert-Roth .

Zeitschrift für Rheumatologie, 2014, 73 (3) :287-289

[40] Targeted immunotherapy strategies in ANCA-associated vasculitis [J].

Puechal, Xavier .

JOINT BONE SPINE, 2019, 86 (03) :321-326

← 1 2 3 4 5 →